
Canopy Growth reported a 13.6% revenue increase to $51.95 million in Q4 2026, driven by its acquisition of MTL Cannabis and strategic recapitalization. Despite missing profit estimates with an adjusted loss per share of $0.29, the loss narrowed significantly from the previous year. The company aims to leverage its position as Canada's leading medical cannabis firm to expand into Europe, expecting overall revenue growth and improved margins in fiscal 2027. Integration of MTL Cannabis may delay stronger profit gains to the second half of the year.